跳至主要内容
临床试验/NCT01500473
NCT01500473终止2 期

Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome

Children's Hospital Los Angeles1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
1
试验地点
1
主要终点
Hypercapnic Ventilatory Response

研究概览

简要总结

Background: Congenital Central Hypoventilation Syndrome (CCHS) is a rare disorder of automatic control of breathing. This disease can manifest as early as birth. Patients with this disease have a fundamental lack of central drive breathing. They do not mount any responses to hypoxia or hypercapnia during sleep or wakefulness. This places them at risk of injury or death whenever they are not consciously breathing. They require lifelong assisted ventilation while sleeping, and some while awake. Progesterone is a known respiratory stimulant in normal individuals, and it has been shown in one study of 2 patients that this drug may improve CO2 responsiveness in patients with CCHS. However, this observation requires confirmation.

Hypothesis: Exogenous progesterone (in oral contraception pills) will improve CO2 responsivity by hyperoxic hypercapnic ventilatory response testing, hypoxic responsivity using 5-breath nitrogen breathing, hyperoxic ventilatory response while breathing 100% oxygen, and improve spontaneous ventilation during sleep in CCHS females >15-years of age. The progesterone will also depress ventilatory response using a hyperoxia test.

Study Methodology: Baseline measures of CO2 and oxygen responsivity, and spontaneous ventilation during sleep, will be performed at baseline and after 3-weeks of taking a progesterone containing oral contraceptive agent. CO2 responsivity will be measured using a hyperoxic hypercapnic ventilatory response test. Hypoxic responsivity will be measured using a 5-breath 100% nitrogen breathing test. Hyperoxic responsivity will be measured by having subjects breathe 100% oxygen for 2-minutes. Subjects will perform an overnight polysomnogram to assess adequacy of gas exchange during spontaneous breathing while asleep. A progesterone containing oral contraception pill will then be given for 3-weeks, and the above measures repeated. Serum progesterone will be measured at baseline and at the time of study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 50 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • diagnosed congenital central hypoventilation syndrome (CCHS)
  • greater than or equal to 16 years of age

排除标准

  • less than 16 years of age
  • poor adherence to medications
  • inability to perform pulmonary maneuvers for tests
  • contraindications to oral contraceptives
  • pulmonary hypertension

研究组 & 干预措施

Females with CCHS > 16 years old on desogestrel

Experimental

open label studied on drug.

干预措施: Desogestrel (Drug)

结局指标

主要结局

Hypercapnic Ventilatory Response

时间窗: 3 weeks

Increase in ventilation with increasing partial pressure of CO2

Time Maintained Ventilation Off Mechanical Ventilation During Sleep.

时间窗: 3 weeks

length of time the subject could breathe adequately spontaneously until SpO2 fell below 80% and or PetCO2 rose above 65 mmHg.

Hypoxic Ventilatory Response

时间窗: 3 weeks

Increase in minute ventilation as oxygen saturation of hemoglobin falls.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iris Perez

Principal Investigator

Children's Hospital Los Angeles

研究点 (1)

Loading locations...

相似试验